Endothelial dysfunction and immunothrombosis in sepsis

E Maneta, E Aivalioti, S Tual-Chalot… - Frontiers in …, 2023 - frontiersin.org
Sepsis is a life-threatening clinical syndrome characterized by multiorgan dysfunction
caused by a dysregulated or over-reactive host response to infection. During sepsis, the …

Disseminated intravascular coagulation: an update on pathogenesis, diagnosis, and therapeutic strategies

C Papageorgiou, G Jourdi, E Adjambri… - Clinical and applied …, 2018 - journals.sagepub.com
Disseminated intravascular coagulation (DIC) is an acquired clinicobiological syndrome
characterized by widespread activation of coagulation leading to fibrin deposition in the …

Disseminated intravascular coagulation in sepsis

S Zeerleder, CE Hack, WA Wuillemin - Chest, 2005 - Elsevier
Disseminated intravascular coagulation is a frequent complication of sepsis. Coagulation
activation, inhibition of fibrinolysis, and consumption of coagulation inhibitors lead to a …

Anticoagulant SERPINs: endogenous regulators of hemostasis and thrombosis

SP Grover, N Mackman - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Appropriate activation of coagulation requires a balance between procoagulant and
anticoagulant proteins in blood. Loss in this balance leads to hemorrhage and thrombosis. A …

Antithrombin: a new look at the actions of a serine protease inhibitor

J Roemisch, E Gray, JN Hoffmann… - Blood coagulation & …, 2002 - journals.lww.com
Antithrombin (AT) is a plasma-derived, single-chain glycoprotein with a molecular weight of
58 kDa. It is a serine protease inhibitor (serpin), sharing about 30% homology in amino acid …

Immunotherapy of sepsis

T Van Der Poll - The Lancet infectious diseases, 2001 - thelancet.com
Sepsis is a clinical syndrome that results from a systemic host response to an infection. The
outcome of sepsis is poor, and mortality rates are as high as 30–40%. Sepsis is associated …

Antithrombin III for critically ill patients

M Allingstrup, J Wetterslev, FB Ravn… - Cochrane database …, 2016 - cochranelibrary.com
Background Critical illness is associated with uncontrolled inflammation and vascular
damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an …

Modulation of hemostatic mechanisms in bacterial infectious diseases

H Tapper, H Herwald - Blood, The Journal of the American …, 2000 - ashpublications.org
Life-threatening complications from bacterial infections are a major and growing clinical
problem, aggravated by the emergence and spread of antibiotic resistance in bacterial …

Antithrombin III inhibits nuclear factor κB activation in human monocytes and vascular endothelial cells

C Oelschläger, J Römisch, A Staubitz… - Blood, The Journal …, 2002 - ashpublications.org
The serpin antithrombin III (AT III), the most important natural inhibitor of thrombin activity,
has been shown to exert marked anti-inflammatory properties and proven to be efficacious …

Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation

M Franchini, G Lippi, F Manzato - Thrombosis Journal, 2006 - Springer
Disseminated intravascular coagulation (DIC) is a disorder characterized by both acute
generalized, widespread activation of coagulation, which results in thrombotic complications …